Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases

Citation
C. Voit et al., Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases, CANC CYTOP, 90(3), 2000, pp. 186-193
Citations number
32
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER CYTOPATHOLOGY
ISSN journal
0008543X → ACNP
Volume
90
Issue
3
Year of publication
2000
Pages
186 - 193
Database
ISI
SICI code
0008-543X(20000625)90:3<186:UFACIT>2.0.ZU;2-Q
Abstract
BACKGROUND. The early detection and treatment of tumor recurrences in melan oma patients is dependent on reliable, sensitive, and specific techniques t o verify suspected tumor metastases. As of fine-needle aspiration cytology (FNAC) has yet to establish itself in the routine follow-up of melanoma pat ients. METHODS. FNAC procedures were performed in melanoma patients with palpable tumors or nonpalpable, ultrasonigraphically suspicious lesions. Cytodiagnos tic evaluation of fine-needle samples obtained from suspicious lesions was performed morphologically. Findings were validated either by histopathologi c diagnosis or prolonged clinical follow-up. RESULTS. The cytologic examination of 739 FNACs from 330 melanoma patients was conducted within 1 day of sampling. Complications were not observed. Th is study showed a sensitivity of 97.9% and a specificity of 100.0%. Moreove r, in 158 FNACs derived from lesions with a diameter less than 1 cm a sensi tivity of 94.6% was achieved. Diagnosis of metastatic melanoma with unknown primary tumor was established in 20 cases. CONCLUSIONS. FNAC is very reliable for the early detection of melanoma meta stases. FNAC is a swift method free of complications and is able to replace diagnostic surgery completely for nonmalignant lesions in a large number o f patients. Moreover, FNAC is especially useful in combination with ultraso und in melanoma follow-up and can enable diagnosis of lesions smaller than 1 cm without impairment of sensitivity or specificity. (C) 2000 American Ca ncer Society.